14 April 2023
Latham Advises Sobi in Streamlining Nirsevimab Contractual Arrangements
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Steve Chinowsky Lead | Latham & Watkins LLP | Partner | corporate | San Diego |
| Oliver Mobasser | Latham & Watkins LLP | Associate | corporate | London |
| Kirt Switzer | Latham & Watkins LLP | Partner | tax | Bay Area |
| Alex Farris | Latham & Watkins LLP | Associate | tax | Not stated |
| Joshua Holian | Latham & Watkins LLP | Partner | antitrust | Bay Area |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- SobiOther
- Counterparties
- Sanofi (Other)
AstraZeneca (Other)